69
Participants
Start Date
July 31, 2001
Primary Completion Date
September 30, 2009
Study Completion Date
September 30, 2009
trastuzumab
Initial loading does of 4 mg/kg IV, followed by 2 mg/kg IV weekly, until disease progression
paclitaxel
60 mg/m\^2 IV weekly; dose increased to 70 mg/m\^2, and subsequently 80 mg/m\^2, after 2 treatment cycles with no evidence of DLT until disease progression
Myocet
40 mg/m\^2 IV weekly; dose increased to 50 mg/m\^2 IV after 2 treatment cycles with no evidence of DLT for 6 cycles
Madrid
Hoffmann-La Roche
INDUSTRY